Josh Azzopardi can’t guarantee he will break the 10-second barrier on Saturday night at the Sydney Track Classic - but he knows it is coming as a cracking field of Australian sprinters push each other ...

Ayo Edebiri confronts Elon Musk over false Pirates of the Caribbean casting rumor that triggered racial harassment and ...

This has often been referred to as a gold standard technique that every athlete should replicate. Whether it is basketball ...

A new study finds that obesity significantly reduces the effectiveness of urate-lowering therapy in male gout patients, with ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Nephrologist Jason B. Rothschild, MD, recently joined Gayle Guyardo, the host of the globally syndicated health and wellness ...

Usain Bolt has been discussing a potential return to the track for a special All-Star event with fellow former athletes, with ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...